GlassScriptPhysician profile
Gary Jules Kohler
NPI 1881603140
$20,822.77
in general payments reported to CMS, 2019-2025
41 companies · $3,118 in 2025
The $3,118 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,758 · 2020: $1,883 · 2021: $1,972 · 2022: $5,505 · 2023: $3,005 · 2024: $2,581 · 2025: $3,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,704.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,417.67 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $3,393.90 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Intuitive Surgical, INC. | $3,158.59 | 2022-2023 | Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,827.78 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Genzyme Corporation | $862.42 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $861.62 | 2019-2025 | Dupixent |
| Csl Behring | $819.68 | 2019-2025 | Hizentra |
| Grifols USA, LLC | $615.61 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Insmed, INC. | $570.14 | 2019-2025 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $503.90 | 2019-2025 | Opsumit, Uptravi |
| Amgen INC. | $488.69 | 2021-2025 | Tezspire |
| Mylan Specialty L.P. | $467.96 | 2019-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $370.29 | 2022-2025 | Winrevair, Capvaxive, Gardasil 9 |
| Sunovion Pharmaceuticals INC. | $360.35 | 2019-2020 | |
| United Therapeutics Corporation | $326.83 | 2019-2024 | Tyvaso |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $308.69 | 2019-2024 | |
| Ani Pharmaceuticals, INC. | $306.69 | 2023-2025 | Purified Cortrophin Gel |
| Philips North America LLC | $266.22 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Janssen Pharmaceuticals, INC | $222.60 | 2019-2022 | |
| Baxter Healthcare | $216.39 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Bayer Healthcare Pharmaceuticals INC. | $206.98 | 2021-2023 | |
| Genentech USA, INC. | $194.29 | 2019-2023 | Xolair |
| Mallinckrodt Enterprises LLC | $116.94 | 2019 | |
| Verona Pharma, INC. | $113.15 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $111.56 | 2025 | Yupelri |
| Pfizer INC. | $99.39 | 2019-2025 | |
| Fisher & Paykel Healthcare INC | $94.96 | 2019 | |
| Gilead Sciences, INC. | $85.19 | 2019 | |
| Advanced Respiratory, INC | $73.92 | 2019-2020 | |
| Electromed, INC. | $66.89 | 2022 | |
| Abiomed | $57.24 | 2023 | Impella |
| Circassia INC. | $55.71 | 2019-2020 | |
| Pulmonx Corporation | $39.10 | 2024-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Teva Pharmaceuticals USA, INC. | $24.62 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $22.61 | 2024 | Cios Spin |
| Covidien LP | $21.07 | 2019 | |
| La Jolla Pharmaceutical Company | $20.89 | 2025 | Giapreza |
| Mallinckrodt Hospital Products INC. | $15.78 | 2025 | Acthar |
| Haemonetics Corporation | $12.90 | 2023 | |
| Allergan, INC. | $12.24 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Kohler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.